Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
ExcelCSVXML     print

5Gary T Kinasewitz

 

Summary for 2003 [at-glance overview of Gary T Kinasewitz work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Gary T Kinasewitz. According to available data, in 2003 Gary T Kinasewitz published at least 5 articles. This work was completed in collaboration with several authors including Dhainaut, Jean-François and Levy, Howard. Many other authors have collaborated with Gary T Kinasewitz as well. There is at least one grant awarded to support this work.

Gary T Kinasewitz has rank 23 when compared to all other authors using the keyword Protein C. Analysis of the article abstracts and the titles suggests that Gary T Kinasewitz professional interests are focused around "drotrecogin alfa activated", "neutrophil cd10 expression" and "patients severe sepsis". These might also be referred to as "alfa activated", "drotrecogin alfa" or "severe sepsis". Statistical analysis shows that Gary T Kinasewitz's writing is likely to contains terms "activated", "sepsis", "cd10", "alfa", "drotrecogin" and "severe".

Unfortunately, there is not enough information to establish Gary T Kinasewitz affiliation. Luckily, several email addresses are on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for Gary T Kinasewitz]

    loading...

    Do you know Gary T Kinasewitz who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Gary T Kinasewitz]

  • none

Science Trivia (2) [Interactive math & science trivia questions]

   

Year 2003 Charts [Gary T Kinasewitz frequent coauthors and the most common unique vocabulary terms for the selected year]

  • Gary T Kinasewitz - Coauthors & Social Network in 2003Gary T Kinasewitz - Unique Vocabulary, Keywords and Interests in 2003

Historical Performance Charts [graphical overview of Gary T Kinasewitz publication and funding history for the range of years]

  • Gary T Kinasewitz - Publications and Funding History in 2003

Emails (4) [email addresses extracted from Gary T Kinasewitz affiliations]

hidden to prevent spam, click here to reveal

Gary T Kinasewitz Coauthors (19) [all coauthors with the number of joint publications]

3

11Dhainaut, Jean-François

2

7Levy, Howard

2

3Yan, S Betty

2

2Garber, Gary E

2

2Larosa, Steven P

1

18Nelson, David R

1

15Opal, Steven M

1

15Russell, James A

1

10Bernard, Gordon R

1

10Laterre, Pierre-François

1

8Riess, Hanno

1

5Maki, Dennis G

1

5Williams, Mark D

1

2Light, R Bruce

1

2Lorente, José A

1

2Morris, Peter

1

2Stearns-Kurosawa, D J

1

1Kaneko, Toshihiro

1

1Keddissi, Jean I

 

Other [context-specific ads]

Affiliations (5) [condensed summary of the Gary T Kinasewitz affiliations, the leading number and the color conveys importance]

  • 1Service de Reanimation Medicale, Centre Hospitalo-Universitaire Cochin Port-Royal, AP-HP, Paris V University, Paris, France.
    1Department of Intensive Care, Cochin Hospital, Cochin Institute, Cochin Port-Royal Medical School, Paris V University, France.
    1Free Radical Biology and Aging Research, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
    1Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.
    1Brown University School of Medicine, Providence, RI, USA.

Key Opinion Leader In [Gary T Kinasewitz is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 23Protein C | 62Sepsis | 171Inflammation | 537Recombinant Proteins

Keywords (32) [keywords assigned to Gary T Kinasewitz articles by PubMed, the leading number and the color conveys importance]

  • 5Humans | 3Inflammation | 3Recombinant Proteins | 3Protein C | 3Sepsis | 2Double-Blind Method | 2Biological Markers | 2Survival Analysis | 2Anti-Infective Agents | 2Blood Coagulation | 2Dose-Response Relationship, Drug | 1Bacteremia | 1Fibrinolytic Agents | 1Radionuclide Imaging | 1Neutrophils | 1Escherichia coli | 1Thoracoscopy | 1Neprilysin | 1Stem Cells | 1Hydrothorax | 1Immunohistochemistry | 1Liver Cirrhosis | 1Fibrinolysis | 1Flow Cytometry | 1Portasystemic Shunt, Transjugular Intrahepatic | 1Fungi | 1Male | 1Female | 1Gram-Negative Bacterial Infections | 1Endothelium, Vascular | 1Intensive Care Units | 1Thrombosis

Gary T Kinasewitz Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gary T Kinasewitz might be a good expert witness on these terms]

  • 10activated | 8sepsis | 8cd10 | 8alfa | 7drotrecogin | 7severe | 6neutrophil | 6reduced | 6expression | 5response | 5human | 4challenge | 4host | 3baboon | 3vivo | 3causative | 3treatment | 3levels | 3microorganism | 3kg | 2effects | 2analyzed | 2preinjection | 2humans | 2primates | 2nonhuman | 2responses | 2resolved | 2neutrophils | 2systemic | 2lps | 2volunteers
  • 8alfa activated | 7drotrecogin alfa | 7severe sepsis | 6cd10 expression | 5neutrophil cd10 | 4patients severe | 3causative microorganism | 2systemic host | 2sepsis analyzed | 2humans vivo | 2treatment effects | 2nonhuman primates | 2human volunteers | 2effects drotrecogin | 2resolved preinjection | 2microorganism treatment | 2preinjection levels | 2expression nonhuman | 2reduced cd10 | 2reduced neutrophil | 2vivo challenge | 2primates humans | 2analyzed causative | 2responses severe | 2host responses | 2role methodology | 2host coagulopathy | 2activated recombinant | 2coagulopathy response | 2sepsis prowess | 2prowess role | 2inflammatory challenge
  • 7drotrecogin alfa activated | 5neutrophil cd10 expression | 4patients severe sepsis | 2host responses severe | 2causative microorganism treatment | 2systemic host responses | 2primates humans vivo | 2analyzed causative microorganism | 2resolved preinjection levels | 2nonhuman primates humans | 2effects drotrecogin alfa | 2microorganism treatment effects | 2reduced neutrophil cd10 | 2responses severe sepsis | 2treatment effects drotrecogin | 2expression nonhuman primates | 2severe sepsis analyzed | 2sepsis analyzed causative | 2humans vivo challenge | 2cd10 expression nonhuman | 2evaluation committee large | 2alfa activated drotrecogin | 2human activated protein | 2activated protein reduces | 2multicenter phase trial | 2committee large multicenter | 2clinical evaluation committee | 2activated patients severe | 2host coagulopathy response | 2severe sepsis prowess | 2alfa activated recombinant | 2phase trial drotrecogin

Reader's Comments (0) [comments posted by readers of Gary T Kinasewitz profile]

no comments yet

Funding (1) [selected NIH grants to Gary T Kinasewitz and the award amounts for recent years]

  • THE DYNAMICS OF VISCERAL PLEURAL FLUID EXCHANGE (KINASEWITZ, GARY - 1983)
    Grant #Award YearAward Amount, USD
    award information is not available
    Total up to 2003$NA

Gary T Kinasewitz Articles (5) [selected PubMed articles for the year 2003 with the links to a full text at PubMed]